注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Ocugen Inc是一家主要從事2019冠狀病毒疾病研究的生物製藥公司,致力於開發治療盲區疾病和開發疫苗的基因療法。該公司的技術管道包括:COVID-19疫苗(0.5),修飾基因治療平台和視網膜疾病的新型生物療法。COVID-19候選疫苗的重點是開發,製造和商業化COVAXIN,以預防Ocugen-COVAXIN地區人類的COVID-19。COVAXIN是一種全病毒滅活的COVID-19候選疫苗,由滅活的SARS-CoV-2病毒配製。修飾基因治療平台專為視網膜疾病設計,包括色素性視網膜炎(RP),萊伯先天性黑蒙(LCA)和乾性年齡相關性黃斑變性(AMD)。該公司正在開發OCU200,一種用於治療糖尿病性黃斑水腫(DME),糖尿病性視網膜病變(DR)和濕性年齡相關性黃斑變性(AMD)的生物製品候選物。OCU400,其首個候選產品正在使用其修飾基因治療平台開發。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Shankar Musunuri | 60 | 2019 | Co-Founder, CEO & Chairman |
Carl D. Regillo | - | 2019 | Member of Retina Scientific Advisory Board |
Prabhavathi B. Fernandes | 75 | 2020 | Independent Director |
Ramesh Kumar | 68 | 2019 | Independent Director |
Bruce D. Forrest | 61 | 2020 | Vaccine Scientific Advisory Board Member |
Uday B. Kompella | 57 | 2019 | Co-founder & Independent Director |
Joseph W. Westphal | - | 2023 | Member of Business Advisory Board |
David S. Boyer | - | - | Member of Retina Scientific Advisory Board |
Satishchandran Chandrasekhar | - | 2020 | Vaccine Scientific Advisory Board Member |
Geeta Lalwani | - | - | Member of Retina Scientific Advisory Board |
Junge Zhang | 57 | 2019 | Independent Director |
Mark Pennesi | - | 2019 | Member of Retina Scientific Advisory Board |
Marna Cupp Whittington | 76 | 2022 | Independent Director |
Catherine J. Pachuk | 67 | 2020 | Vaccine Scientific Advisory Board Member |
David Fajgenbaum | - | 2020 | Vaccine Scientific Advisory Board Member |
Robert J. Smith | 63 | 2024 | Member of Business Advisory Board |
Connie R. Collingsworth | 65 | 2023 | Member of Business Advisory Board |
Susan Weiss | - | 2020 | Vaccine Scientific Advisory Board Member |
Kirsten M. Castillo | 50 | 2020 | Independent Director |
Patrick J. Toomey | 62 | 2023 | Member of Business Advisory Board |
Dennis C. Carey | 66 | 2023 | Member of Business Advisory Board |
Harvey Rubin | - | 2020 | Vaccine Scientific Advisory Board Member |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核